Similar articles

• Breastfeeding while taking lamivudine or tenofovir disoproxil fumarate: a review of the evidence.

  Ehrhardt S, Xie C, Guo N, Nelson K, Thio CL. Ehrhardt S, et al. Clin Infect Dis. 2015 Jan 15;60(2):275-8. doi: 10.1093/cid/ciu798. Epub 2014 Oct 13. Clin Infect Dis. 2015. PMID: 25313254 Review.
• Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus.

  Greenup AJ, Tan PK, Nguyen V, Glass A, Davison S, Chatterjee U, Holdaway S, Samarasinghe D, Jackson K, Locarnini SA, Levy MT. Greenup AJ, et al. J Hepatol. 2014 Sep;61(3):502-7. doi: 10.1016/j.jhep.2014.04.038. Epub 2014 May 5. J Hepatol. 2014. PMID: 24801414
• Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects.

  Gallant JE, Rodriguez AE, Weinberg WG, Young B, Berger DS, Lim ML, Liao Q, Ross L, Johnson J, Shaefer MS; ESS30009 Study. Gallant JE, et al. J Infect Dis. 2005 Dec 1;192(11):1921-30. doi: 10.1086/498069. Epub 2005 Oct 25. J Infect Dis. 2005. PMID: 16267763 Clinical Trial.
• A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.

  Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, Marks P, Sasadeusz J, Cooper DA, Bowden S, Locarnini S, Ruxrungtham K, Dore GJ. Matthews GV, et al. Hepatology. 2008 Oct;48(4):1062-9. doi: 10.1002/hep.22462. Hepatology. 2008. PMID: 18697216 Clinical Trial.
• Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B infection.

  Jones J, Colquitt J, Shepherd J, Harris P, Cooper K. Jones J, et al. Health Technol Assess. 2010 May;14 Suppl 1:23-9. doi: 10.3310/hta14Suppl1/04. Health Technol Assess. 2010. PMID: 20507800 Review.